Description:

Age Related Macular Degeneration (AMD) has become near epidemic levels and continues to be a leading cause of legal blindness globally.  With advances in intravitreal treatment, it has become very important to identify cases of neovascular (wet) AMD early rather than late.  Despite improvement in technology many AMD patients still arrive late to the retina clinic after significant loss of visual function. Clinicians can do better!  This course will outline a comprehensive review of current imaging options available and the variations in AMD presentation with SDOCT technology, autofluorescence and OCT angiography. In addition the landscape for treatment of neovascular (wet) AMD is ever changing and this course will provide a current update on the many intravitreal and surgical options currently available for the management of neovascular AMD.  In addition, if you want to prevent visual loss from advanced AMD you must first prevent advanced AMD. This course will summarize current micronutrient supplements that should be recommended to our patients.

Course Code:

AOA359-TD

Speaker(s):

Jay Haynie, O.D.

drjay@soundretina.com

Mohammad Rafieetary, O.D.

mrafieetary@charlesretina.com

Credits:

2

AOA Expiration Date:

12/15/2025

Related News

AOA-PAC election report: Optometry has outsized impact on 2024 elections

Tap into the AOA’s interactive 2024 elections map to see how hundreds of pro-optometry U.S. House and Senate candidates fared and learn how advocates can get more involved in the fight in our nation’s capital for patients and the future of the profession.

New AOA clinical guideline puts focus on elevating care of glaucoma patients

Guideline provides list of evidence- and consensus-based recommendations for care of primary open-angle glaucoma, the most common type of glaucoma. How many of these recommendations do you follow?

Introducing the new CMS G2211 code

In certain cases, this new code can be used for Medicare claims. Here’s how it works.